136 related articles for article (PubMed ID: 24718009)
1. Ductal prostatic adenocarcinoma: magnetic resonance imaging documenting the effect of hormone-radiotherapy.
Hardie AD; Naveed MA; Clarke HS
J Coll Physicians Surg Pak; 2014 Mar; 24 Suppl 1():S55-6. PubMed ID: 24718009
[TBL] [Abstract][Full Text] [Related]
2. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases.
Tavora F; Epstein JI
Am J Surg Pathol; 2008 Jul; 32(7):1060-7. PubMed ID: 18496142
[TBL] [Abstract][Full Text] [Related]
3. Pure prostatic papillary adenocarcinoma with ductal features.
Yamashita S; Inaba Y; Soma F; Katayama Y
Hinyokika Kiyo; 2005 Mar; 51(3):207-9; discussion 210. PubMed ID: 15852679
[TBL] [Abstract][Full Text] [Related]
4. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
[TBL] [Abstract][Full Text] [Related]
5. Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.
Teh BS; Ayala G; Aguilar L; Mai WY; Timme TL; Vlachaki MT; Miles B; Kadmon D; Wheeler T; Caillouet J; Davis M; Carpenter LS; Lu HH; Chiu JK; Woo SY; Thompson T; Aguilar-Cordova E; Butler EB
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1520-9. PubMed ID: 15050332
[TBL] [Abstract][Full Text] [Related]
6. [Prostatic cancer with cystic formation: a case report].
Takayama H; Arai Y; Meguro N; Maeda O; Saiki S; Kinouchi T; Kuroda M; Usami M; Kotake T
Hinyokika Kiyo; 1996 Dec; 42(12):977-80. PubMed ID: 9013236
[TBL] [Abstract][Full Text] [Related]
7. A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer.
D'Amico AV; Whittington R; Malkowicz SB; Schultz D; Schnall M; Tomaszewski JE; Wein A
J Urol; 1995 Jul; 154(1):131-8. PubMed ID: 7539857
[TBL] [Abstract][Full Text] [Related]
8. [Endometrioid adenocarcinoma of the prostate: report of 3 cases].
Uemura M; Nakagawa M; Kanno N; Nishimura K; Miyoshi S; Kawano K
Hinyokika Kiyo; 2004 Nov; 50(11):825-8. PubMed ID: 15628548
[TBL] [Abstract][Full Text] [Related]
9. Multidisciplinary treatment of synchronous primary rectal and prostate cancers.
Colonias A; Farinash L; Miller L; Jones S; Medich DS; Greenberg L; Miller R; Parda DS
Nat Clin Pract Oncol; 2005 May; 2(5):271-4; quiz 1 p following 274. PubMed ID: 16264963
[TBL] [Abstract][Full Text] [Related]
10. Extraprostatic extension of prostatic adenocarcinoma on needle core biopsy: report of 72 cases with clinical follow-up.
Miller JS; Chen Y; Ye H; Robinson BD; Brimo F; Epstein JI
BJU Int; 2010 Aug; 106(3):330-3. PubMed ID: 20002671
[TBL] [Abstract][Full Text] [Related]
11. Prostatic ductal adenocarcinoma: an aggressive tumour variant unrecognized on T2 weighted magnetic resonance imaging (MRI).
Schieda N; Coffey N; Gulavita P; Al-Dandan O; Shabana W; Flood TA
Eur Radiol; 2014 Jun; 24(6):1349-56. PubMed ID: 24687527
[TBL] [Abstract][Full Text] [Related]
12. Preoperative assessment of prostate cancer using prebiopsy MRI.
Min JH; Park BK; Park JJ; Park SY; Kim CK
AJR Am J Roentgenol; 2014 Aug; 203(2):341-6. PubMed ID: 25055269
[TBL] [Abstract][Full Text] [Related]
13. Early salvage radiation therapy combined with short-term hormonal therapy in recurrent prostate cancer after radical prostatectomy: single-institution 4-year data on outcome, toxicity, health-related quality of life and co-morbidities from 184 consecutive patients treated with 70 Gy.
Cortés-González JR; Castellanos E; Sandberg K; Eriksson MH; Wiklund P; Carlsson S; Cohn-Cedermark G; Harmenberg U; Gustafsson O; Levitt SH; Lennernäs B; Brandberg Y; Márquez M; Kälkner KM; Nilsson S
Int J Oncol; 2013 Jan; 42(1):109-17. PubMed ID: 23151842
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant hormonal therapy in stage C adenocarcinoma of the prostate.
Andros EA; Danesghari F; Crawford ED
Clin Invest Med; 1993 Dec; 16(6):510-5. PubMed ID: 7516835
[TBL] [Abstract][Full Text] [Related]
15. Present and future management of prostate cancer.
de Vere White R
Cancer Biother Radiopharm; 2000 Apr; 15(2):121-5. PubMed ID: 10803316
[No Abstract] [Full Text] [Related]
16. [EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer].
Mottet N; Bellmunt J; Bolla M; Joniau S; Mason M; Matveev V; Schmid HP; van der Kwast T; Wiegel T; Zattoni F; Heidenreich A
Actas Urol Esp; 2011; 35(10):565-79. PubMed ID: 21757258
[TBL] [Abstract][Full Text] [Related]
17. Incidence, etiology, location, prevention and treatment of positive surgical margins after radical prostatectomy for prostate cancer.
Wieder JA; Soloway MS
J Urol; 1998 Aug; 160(2):299-315. PubMed ID: 9679867
[TBL] [Abstract][Full Text] [Related]
18. [A case of ductal carcinoma of the prostate after transurethral resection of prostate].
Izumi K; Kanno H; Umemoto S; Hasumi H; Osada Y; Ota J; Tsuchiya F; Ogino I; Harada M
Hinyokika Kiyo; 2007 May; 53(5):315-8. PubMed ID: 17561717
[TBL] [Abstract][Full Text] [Related]
19. Prognostic importance of Gleason 7 disease among patients treated with external beam radiation therapy for prostate cancer: results of a detailed biopsy core analysis.
Spratt DE; Zumsteg Z; Ghadjar P; Pangasa M; Pei X; Fine SW; Yamada Y; Kollmeier M; Zelefsky MJ
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1254-61. PubMed ID: 23182392
[TBL] [Abstract][Full Text] [Related]
20. Adenocarcinoma of the prostate with Gleason score 9-10 on core biopsy: correlation with findings at radical prostatectomy and prognosis.
Ellis CL; Partin AW; Han M; Epstein JI
J Urol; 2013 Dec; 190(6):2068-73. PubMed ID: 23727307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]